Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs.
Komazin
Gloria
G
Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1078, USA.
Ptak
Roger G
RG
Emmer
Brian T
BT
Townsend
Leroy B
LB
Drach
John C
JC
D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D001562:Benzimidazoles / Q000737:chemistry / Q000494:pharmacology*; D003587:Cytomegalovirus / Q000187:drug effects*; D015195:Drug Design; D006801:Humans; D012263:Ribonucleosides / Q000737:chemistry / Q000494:pharmacology; D012266:Ribose; D004004:Dichlororibofuranosylbenzimidazole / Q000031:analogs & derivatives
D000998:Antiviral Agents; D001562:Benzimidazoles; D012263:Ribonucleosides; D012266:Ribose; C400401:maribavir; D004004:Dichlororibofuranosylbenzimidazole